References:
- Urano M, Abe M, Horibe Y, Kuroda M, Mizoguchi Y, Sakurai K, Naito K.
Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary
glands. Pathol Res Pract. 2002;198(4):305-10.
- Tasaki T, Matsuyama A, Tabata T, Suzuki H, Yamada S, Sasaguri Y,
Hisaoka M. Sclerosing mucoepidermoid carcinoma with eosinophilia of
the salivary gland: case report and review of the literature. Pathol
Int. 2013 Feb;63(2):125-31.
- Kobayashi Y, Satoh K, Aizawa T, Urano M, Kuroda M, Mizutani H. Local
recurrence of sclerosing mucoepidermoid carcinoma with eosinophilia in
the upper lip: a case report. J Med Case Rep. 2015 Feb 24;9:41. doi:
10.1186/s13256-015-0525-8. PMID: 25888867; PMCID: PMC4344751.
- Harada H, Toyozumi Y, Sasaguri T, Kuyama K, Nakatsuka SI, Kurose A.
Sclerosing mucoepidermoid carcinoma of the salivary glands: report of
three cases with special concern to the counterpart accompanied by
eosinophilia. Med Mol Morphol. 2021 Sep;54(3):265-274.
- Alena Skalova et al., editors. Chapter 5. Salivary gland tumours in:
WHO Classification of Tumours Editorial Board. Head and neck tumours.
Lyon (France): International Agency for Research on Cancer;
forthcoming. (WHO classification of tumours series, 5th ed.; vol. 9).
- Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J.
Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia: a
distinctive low-grade malignancy arising from the metaplastic
follicles of Hashimoto’s thyroiditis. Am J Surg Pathol.
1991;15:438–48.
- Shah AA, La Fortune K, Miller C, Mills SE, Baloch Z, LiVolsi V, Dacic
S, Mahaffey AL, Nikiforova M, Nikiforov YE, Seethala RR. Thyroid
sclerosing mucoepidermoid carcinoma with eosinophilia: a
clinicopathologic and molecular analysis of a distinct entity. Mod
Pathol. 2017 Mar;30(3):329-339.
- Heptinstall L, Carroll C, Siddiqi J, Kamel D, Petkar M. Sclerosing
Mucoepidermoid Carcinoma of the Submandibular Gland Presenting as
Chronic Sialadenitis: A Case Report and Review of Literature. Head
Neck Pathol. 2017 Dec;11(4):506-512.
- Jee KJ, Persson M, Heikinheimo K, Passador-Santos F, Aro K, Knuutila
S, Odell EW, Mäkitie A, Sundelin K, Stenman G, Leivo I. Genomic
profiles and CRTC1-MAML2 fusion distinguish different subtypes of
mucoepidermoid carcinoma. Mod Pathol. 2013 Feb;26(2):213-22.
- West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K,
Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless
CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M. A
landscape effect in tenosynovial giant-cell tumor from activation of
CSF1 expression by a translocation in a minority of tumor cells. Proc
Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5.
- Cheung FMF, So TYC, Sung THT, Lam YL. Diffuse-Type Tenosynovial Giant
Cell Tumour Involving Bone Masquerading as Langerhans Cell
Histiocytosis. Case Rep Med. 2022 Sep 15; 2022:1992541.
- Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O’Connell JX, Huntsman
D, van de Rijn M, Gilks CB, West RB. Translocation and expression of
CSF1 in pigmented villonodular synovitis, tenosynovial giant cell
tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg
Pathol. 2007 Jun;31(6):970-6.
Acknowledgement: All authors have no conflicts of interest in this
publication. We would like to thank the patient concerned for signing
the informed consent for publication of clinical data and figures. We
would like to thank Department of Pathology, Queen Mary Hospital, for
the slide review.